Evidence map›Paper›PMID 28205580›Full record

ArticleScientific reports2017

Accelerated biodegradation of silk sutures through matrix metalloproteinase activation by incorporating 4-hexylresorcinol.

You-Young Jo, HaeYong Kweon, Dae-Won Kim, Min-Keun Kim, Seong-Gon Kim, Jwa-Young Kim, Weon-Sik Chae, Sam-Pyo Hong, Young-Hwan Park, Si Young Lee and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Recent Advances in Silk Fibroin Derived fromJournal of functional biomaterials · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Multiple ways for the same destination: bone regeneration.Maxillofacial plastic and reconstructive surgery · 2022
    Review
  10. Article
  11. Article
  12. 4-Hexylresorcinol-in duced angiogenesis potential in human endothelial cells.Maxillofacial plastic and reconstructive surgery · 2020
    Article
  13. Immunomodulation for maxillofacial reconstructive surgery.Maxillofacial plastic and reconstructive surgery · 2020
    Review
  14. Immunomodulation and smart materials for maxillofacial tissue engineering.Maxillofacial plastic and reconstructive surgery · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

You-Young JoRural Development Administration, Wanju-Gun 55365, South Korea.
HaeYong KweonRural Development Administration, Wanju-Gun 55365, South Korea.
Dae-Won KimDept. of Oral Biochemistry, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, South Korea.
Min-Keun KimDept. of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, South Korea.
Seong-Gon KimDept. of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, South Korea.
Jwa-Young KimDept. of Oral and Maxillofacial Surgery, College of Medicine, Hallym University, Anyang 14068, South Korea.
Weon-Sik ChaeAnalysis Research Division, Daegu Center, Korea Basic Science Institute, South Korea.
Sam-Pyo HongDept. of Oral Pathology, College of Dentistry, Seoul National University, Seoul 03080, South Korea.
Young-Hwan ParkDepartment of Biosystems &Biomaterials Science and Engineering, Seoul National University, South Korea.
Si Young LeeDept. of Oral Microbiology, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, South Korea.
Je-Yong ChoiSchool of Biochemistry and Cell Biology, Skeletal Diseases Genome Research Center, Kyungpook National University, Daegu 700-842, Korea.
Gangneung–Wonju National University · KRRural Development Administration · KRSeoul National University · KRHallym University · KRKorea Basic Science Institute · KRKyungpook National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silk suture material is primarily composed of silk fibroin and regarded as a non-resorbable material. It is slowly degraded by proteolysis when it is implanted into the body. 4-Hexylresorcinol (4HR) is a well-known antiseptic. In this study, the biodegradability of 4HR-incorporated silk sutures were compared to that of untreated silk sutures and polyglactin 910 sutures, a commercially available resorbable suture. 4HR-incorporated silk sutures exhibited anti-microbial properties. Matrix metalloproteinase (MMP) can digest a wide spectrum of proteins. 4HR increased MMP-2, -3, and -9 expression in RAW264.7 cells. MMP-2, -3, and -9 were able to digest not only silk fibroin but also silk sutures. Consequently, 59.5% of the 4HR-incorporated silk suture material remained at 11 weeks after grafting, which was similar to that of polyglactin 910 degradation (56.4% remained). The residual amount of bare silk suture material at 11 weeks after grafting was 91.5%. The expression levels of MMP-2, -3 and -9 were high in the 4HR-incorporated silk suture-implanted site 12 weeks after implantation. In conclusion, 4HR-treated silk sutures exhibited anti-microbial properties and a similar level of bio-degradation to polyglactin 910 sutures and induced higher expression of MMP-2, -3, and -9 in macrophages.

Indexed as

SuturesAnti-Infective AgentsBiocompatible MaterialsFibroinsHexylresorcinolImmunohistochemistryMacrophagesMatrix MetalloproteinasesProteolysisSilkSpectroscopy, Fourier Transform InfraredTensile StrengthAnti-Infective AgentsBiocompatible MaterialsFibroinsHexylresorcinolMatrix MetalloproteinasesSilk

Identifiers

PMID28205580
PMCPMC5304327
OpenAlexW2588511232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.